Stock PHRX PHARMADRUG INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Pharmadrug Inc.

Equities

PHRX

CA71716W2040

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 12:51:59 30/04/2024 am IST 		5-day change 1st Jan Change
0.03 CAD 0.00% Intraday chart for Pharmadrug Inc. 0.00% -45.45%
16/04 PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine MT
13/03 Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine CI

Business Summary

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.

Sales per Business

CAD in Million2021Weight2022Weight Delta
Medical Cannabis
98.3 %
0 98.4 % 0 98.3 % -56.78%
Online Slim Winkel
1.7 %
0 0.2 % 0 1.7 % +353.83%

Sales per region

CAD in Million2021Weight2022Weight Delta
Germany
98.3 %
0 98.4 % 0 98.3 % -56.78%
United States
1.7 %
0 0.2 % 0 1.7 % +353.83%

Managers

Managers TitleAgeSince
Robert Steen CEO
 Chief Executive Officer - 06/23/06
Paul van Slyke CTO
 Chief Tech/Sci/R&D Officer - 13/21/13

Members of the board

Members of the board TitleAgeSince
Paul McClory BRD
 Director/Board Member 80 20/16/20
Al Quong BRD
 Director/Board Member 58 31/19/31
David Kideckel CHM
 Chairman - 30/21/30
Nikolai Vassev BRD
 Director/Board Member 31 19/19/19
Robert Steen CEO
 Chief Executive Officer - 06/23/06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 104,556,647 103,638,181 ( 99.12 %) 0 99.12 %

Shareholders

NameEquities%Valuation
VERTICAL PEAK HOLDINGS INC.
1.463 %
1,279,016 1.463 % 34 533 $
Jeremy Fiederer
1.144 %
1,000,000 1.144 % 27 000 $
Daniel Cohen
1.001 %
875,608 1.001 % 23 641 $
Paul McClory
0.3921 %
342,857 0.3921 % 9 257 $
Kyle Appleby
0.000000 %
0 0.000000 % - $
Al Quong
0.000000 %
0 0.000000 % - $
Jim Frazier
0.000000 %
0 0.000000 % - $
David Kideckel
0.000000 %
0 0.000000 % - $
Keith Li
0.000000 %
0 0.000000 % - $
Nikolai Vassev
0.000000 %
0 0.000000 % - $

Company contact information

Pharmadrug, Inc.

77 King Street West Suite 2905

M5K 1H1, Toronto

+

http://www.pharmadrug.co
address Pharmadrug Inc.(PHRX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sales per region

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
PHARMADRUG INC. Stock Pharmadrug Inc.
-45.45% 2.29M
MCKESSON CORPORATION Stock McKesson Corporation
+15.79% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.09% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-1.47% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.95% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.48% 7.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+15.26% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 3.93B
GALENICA AG Stock Galenica AG
-3.02% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.10% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. PHRX Stock
  4. Company Pharmadrug Inc.